Recent studies suggest that ErbB2 as well as EGFR can also be trans-activated by cytokines including Interleukin-8 (IL8; CXCL8) [11], a neutrophil chemoattractant and an angiogenic factor with tumor promoting properties [12, 13]. Here, CXCL8 is linked to neoplasm.